These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31535298)

  • 41. Artificial and bioartificial liver devices: present and future.
    Carpentier B; Gautier A; Legallais C
    Gut; 2009 Dec; 58(12):1690-702. PubMed ID: 19923348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver cell therapy and tissue engineering for transplantation.
    Vacanti JP; Kulig KM
    Semin Pediatr Surg; 2014 Jun; 23(3):150-5. PubMed ID: 24994529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New devices in liver replacement therapy].
    Rifai K; Bahr MJ; Schneider A; Ott M; Manns MP
    Med Klin (Munich); 2003 Dec; 98(12):750-3. PubMed ID: 14685676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Artificial liver support: a real step forward.
    Saliba F; Samuel D
    Minerva Med; 2015 Feb; 106(1):35-43. PubMed ID: 25367058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Predictive value of pediatrics end-stage liver disease or model for end-stage liver disease score in the prognosis of pediatric acute liver failure treated with artificial liver support system].
    Jinhao T; Weiming C; Jing H; Jun H; Jian M; Peng S; Zhujin L; Guoping L; Yimin Z
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):280-4. PubMed ID: 26182503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems.
    Hassanein T
    Metab Brain Dis; 2017 Apr; 32(2):303-306. PubMed ID: 28013444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Artificial and bioartificial liver support systems for acute and acute-on-chronic liver failure: a meta-analysis].
    Liu Y; Kang YZ; Xia WZ; Zhou HC; Wang Y; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1529-32. PubMed ID: 19726283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial liver support system in China: a review over the last 30 years.
    Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
    Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver replacement therapy.
    Tritto G; Davies NA; Jalan R
    Semin Respir Crit Care Med; 2012 Feb; 33(1):70-9. PubMed ID: 22447262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review and meta-analysis of survival following extracorporeal liver support.
    Stutchfield BM; Simpson K; Wigmore SJ
    Br J Surg; 2011 May; 98(5):623-31. PubMed ID: 21462172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical care of the end-stage liver disease patient awaiting liver transplantation.
    Findlay JY; Fix OK; Paugam-Burtz C; Liu L; Sood P; Tomlanovich SJ; Emond J
    Liver Transpl; 2011 May; 17(5):496-510. PubMed ID: 21506240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.
    Naruse K; Tang W; Makuuch M
    World J Gastroenterol; 2007 Mar; 13(10):1516-21. PubMed ID: 17461442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.
    Debray D; Yousef N; Durand P
    Paediatr Drugs; 2006; 8(1):1-13. PubMed ID: 16494508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007-2015.
    Wiesmann T; Hoenl D; Wulf H; Irqsusi M
    BMC Gastroenterol; 2019 Sep; 19(1):160. PubMed ID: 31481009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ['Artificial support in case of hepatic failure'; a report from the Dutch Health Council].
    Chamuleau RA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):221-3. PubMed ID: 15719830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.
    Riordan SM; Williams R
    J Hepatol; 2000; 32(1 Suppl):63-76. PubMed ID: 10728795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioartificial liver: current status.
    Pless G; Sauer IM
    Transplant Proc; 2005 Nov; 37(9):3893-5. PubMed ID: 16386576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure.
    Xia Q; Dai X; Huang J; Xu X; Yang Q; Liu X; Chen Y; Li L
    Int J Artif Organs; 2014 Jun; 37(6):442-54. PubMed ID: 25008954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular adsorbent recirculating system and bioartificial devices for liver failure.
    Bañares R; Catalina MV; Vaquero J
    Clin Liver Dis; 2014 Nov; 18(4):945-56. PubMed ID: 25438293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.